1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Buparlisib: new trials by email Literature Review of Buparlisib trials Research Report on Buparlisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Paclitaxel, BKM120 matching placebo, BKM120 - Breast Cancer | Phase 2 / Phase 3 | Completed | Novartis Pharmaceuticals | 416 | 2012-08-01 | 2017-03-09 |
Breast Neoplasms (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Neoplasm Metastasis (1)
Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Russia (1)